annb0t
Top 20
ResMed Inc. RMD is well-poised for growth in the coming quarters, backed by the global supply of its cloud-connected platforms, AirSense10 and AirSense11. The strong uptake of the myAir app with AirSense11 is likely to drive higher adherence to therapy in patients. However, the company has been witnessing increased operating expenses in the past few quarters.
Over the past three months, this Zacks Rank #3 (Hold) stock has gained 19.9% compared with 21.9% rise of the industry and a 10.3% rise of...
>>> Read more: Here's Why Investors Should Retain ResMed (RMD) Stock for Now
Over the past three months, this Zacks Rank #3 (Hold) stock has gained 19.9% compared with 21.9% rise of the industry and a 10.3% rise of...
>>> Read more: Here's Why Investors Should Retain ResMed (RMD) Stock for Now
